| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |